Autologous CMV-specific CD8+ T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous CMV-specific CD8+ T Cells, covering 2015-06-08 to 2015-06-08. Get the full timeline:
Most recent: Clinical Trial Update: Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation [Phase 1, Phase 2]